ABBV
AbbVie Inc.$196.56-0.86 (-0.44%)Prev Close$197.38·MCap$360.31B·P/E83.45·Vol2.40M·Yield0.03%
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
4
$17.42M
◆
Net Activity
Net Seller
$17.42M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at AbbVie Inc. (ABBV) has been exclusively selling, with 0 insider purchases totaling $0.00 and 4 insider sales totaling $17.42M. The most recent insider transaction was by Purdue David Ryan (officer: SVP, Controller), who sold $1.22M worth of shares on Mar 6, 2026. AbbVie Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry, with a market cap of $360.31B.
ABBV Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Purdue David Ryan | officer: SVP, Controller | Sell | 5,230 | $233.56 | $1.22M | 2,654-66% |
| Feb 27, 2026 | Siatis Perry C | officer: EVP, GC AND SECRETARY | Sell | 22,381 | $230.00 | $5.15M | 38,137-37% |
| Aug 14, 2025 | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | Sell | 42,370 | $198.42 | $8.41M | 0 |
| Aug 5, 2025 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 13,295 | $198.51 | $2.64M | 0 |
| Mar 31, 2025 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 58,832 | $210.08 | $12.36M | 0 |
| Mar 18, 2025 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Sell | 17,644 | $212.34 | $3.75M | 0 |
| Mar 4, 2025 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 11,230 | $205.02 | $2.30M | 0 |
| Mar 4, 2025 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Sell | 10,973 | $205.02 | $2.25M | 0 |
| Mar 4, 2025 | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | Sell | 17,056 | $205.02 | $3.50M | 0 |
| Mar 4, 2025 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 20,226 | $205.02 | $4.15M | 0 |
| Feb 28, 2025 | Buckbee Kevin K | SVP, CONTROLLER | Sell | 3,699 | $205.02 | $758.4K | 0 |
| Feb 28, 2025 | GONZALEZ RICHARD A | Director | Sell | 171,837 | $205.27 | $35.27M | 0 |
| Feb 28, 2025 | Michael Robert A. | CHIEF EXECUTIVE OFFICER | Sell | 27,186 | $205.02 | $5.57M | 0 |
| Feb 28, 2025 | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | Sell | 68,071 | $205.78 | $14.01M | 0 |
| Feb 28, 2025 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 35,770 | $207.88 | $7.44M | 0 |
| Feb 28, 2025 | Thakkar Roopal | EVP, R&D and CSO | Sell | 4,678 | $205.02 | $959.1K | 0 |
| Feb 26, 2025 | Buckbee Kevin K | SVP, CONTROLLER | Sell | 18,944 | $203.41 | $3.85M | 0 |
| Feb 20, 2025 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 5,778 | $197.90 | $1.14M | 0 |
| Dec 16, 2024 | Buckbee Kevin K | SVP, CONTROLLER | Sell | 1,800 | $172.24 | $310.0K | 0 |
| Aug 5, 2024 | GONZALEZ RICHARD A | EXECUTIVE CHAIRMAN OF BOARD | Sell | 66,500 | $186.52 | $12.40M | 0 |
| Jul 17, 2024 | GONZALEZ RICHARD A | EXECUTIVE CHAIRMAN OF BOARD | Sell | 282,845 | $175.00 | $49.50M | 0 |
| Mar 20, 2024 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 21,082 | $176.30 | $3.72M | 0 |
| Mar 18, 2024 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 58,949 | $178.79 | $10.54M | 0 |
| Mar 1, 2024 | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | Sell | 75,680 | $177.27 | $13.42M | 0 |
| Feb 28, 2024 | Buckbee Kevin K | SVP, CONTROLLER | Sell | 10,483 | $177.84 | $1.86M | 0 |
| Feb 28, 2024 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 16,771 | $178.99 | $3.00M | 0 |
| Feb 28, 2024 | GONZALEZ RICHARD A | CHAIRMAN OF THE BOARD AND CEO | Sell | 248,865 | $178.03 | $44.31M | 0 |
| Feb 28, 2024 | Hudson Thomas J | SVP, CSO, GLOBAL RESEARCH | Sell | 20,634 | $178.99 | $3.69M | 0 |
| Feb 28, 2024 | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | Sell | 106,517 | $177.35 | $18.89M | 0 |
| Feb 28, 2024 | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | Sell | 23,847 | $178.99 | $4.27M | 0 |
| Feb 28, 2024 | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | Sell | 23,966 | $178.99 | $4.29M | 0 |
| Feb 28, 2024 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 17,776 | $178.10 | $3.17M | 0 |
| Feb 28, 2024 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 26,121 | $178.99 | $4.68M | 0 |
| Feb 28, 2024 | Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | Sell | 4,914 | $178.99 | $879.6K | 0 |
| Feb 23, 2024 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Sell | 25,774 | $178.14 | $4.59M | 0 |
| Feb 23, 2024 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 13,753 | $177.51 | $2.44M | 0 |
| Feb 21, 2024 | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | Sell | 52,870 | $173.71 | $9.18M | 0 |
| Feb 2, 2024 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 2,919 | $170.00 | $496.2K | 0 |
| Dec 26, 2023 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 2,912 | $154.72 | $450.5K | 0 |
| Jul 31, 2023 | GONZALEZ RICHARD A | CHAIRMAN OF THE BOARD AND CEO | Sell | 78,500 | $148.71 | $11.67M | 0 |
| May 11, 2023 | Strom Carrie C | SVP & PRES GLOBAL ALLERG AESTH | Sell | 2,876 | $146.42 | $421.1K | 0 |
| Apr 25, 2023 | Sorg Elaine K. | SVP, US COMMERCIAL OPERATIONS | Sell | 6,130 | $165.00 | $1.01M | 0 |
| Apr 17, 2023 | Sorg Elaine K. | SVP, US COMMERCIAL OPERATIONS | Sell | 7,499 | $161.67 | $1.21M | 0 |
| Apr 3, 2023 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 3,520 | $160.00 | $563.2K | 0 |
| Apr 3, 2023 | Sorg Elaine K. | SVP, US COMMERCIAL OPERATIONS | Sell | 15,002 | $160.03 | $2.40M | 0 |
| Mar 13, 2023 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 53,125 | $152.28 | $8.09M | 0 |
| Mar 5, 2023 | Strom Carrie C | SVP & PRES GLOBAL ALLERG AESTH | Sell | 449 | $156.06 | $70.1K | 0 |
| Feb 28, 2023 | Durkin Brian L | VP, CONTROLLER | Sell | 11,182 | $154.28 | $1.73M | 0 |
| Feb 28, 2023 | GONZALEZ RICHARD A | CHAIRMAN OF THE BOARD AND CEO | Sell | 113,810 | $154.28 | $17.56M | 0 |
| Feb 28, 2023 | Hudson Thomas J | SVP, R&D AND CSO | Sell | 27,922 | $154.28 | $4.31M | 0 |
Showing 1–50 of 117
1 / 3
ABBV Insider Buying Activity
The following table shows recent insider purchases of AbbVie Inc. (ABBV) stock reported via SEC Form 4 filings.
No insider buying activity found for ABBV in the last 12 months.
ABBV Insider Selling Activity
The following table shows recent insider sales of AbbVie Inc. (ABBV) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Purdue David Ryan | officer: SVP, Controller | Sell | 5,230 | $233.56 | $1.22M | 2,654-66% |
| Feb 27, 2026 | Siatis Perry C | officer: EVP, GC AND SECRETARY | Sell | 22,381 | $230.00 | $5.15M | 38,137-37% |
| Aug 14, 2025 | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | Sell | 42,370 | $198.42 | $8.41M | 0 |
| Aug 5, 2025 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 13,295 | $198.51 | $2.64M | 0 |
| Mar 31, 2025 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 58,832 | $210.08 | $12.36M | 0 |
| Mar 18, 2025 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Sell | 17,644 | $212.34 | $3.75M | 0 |
| Mar 4, 2025 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 11,230 | $205.02 | $2.30M | 0 |
| Mar 4, 2025 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Sell | 10,973 | $205.02 | $2.25M | 0 |
| Mar 4, 2025 | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | Sell | 17,056 | $205.02 | $3.50M | 0 |
| Mar 4, 2025 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 20,226 | $205.02 | $4.15M | 0 |
| Feb 28, 2025 | Buckbee Kevin K | SVP, CONTROLLER | Sell | 3,699 | $205.02 | $758.4K | 0 |
| Feb 28, 2025 | GONZALEZ RICHARD A | Director | Sell | 171,837 | $205.27 | $35.27M | 0 |
| Feb 28, 2025 | Michael Robert A. | CHIEF EXECUTIVE OFFICER | Sell | 27,186 | $205.02 | $5.57M | 0 |
| Feb 28, 2025 | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | Sell | 68,071 | $205.78 | $14.01M | 0 |
| Feb 28, 2025 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 35,770 | $207.88 | $7.44M | 0 |
| Feb 28, 2025 | Thakkar Roopal | EVP, R&D and CSO | Sell | 4,678 | $205.02 | $959.1K | 0 |
| Feb 26, 2025 | Buckbee Kevin K | SVP, CONTROLLER | Sell | 18,944 | $203.41 | $3.85M | 0 |
| Feb 20, 2025 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 5,778 | $197.90 | $1.14M | 0 |
| Dec 16, 2024 | Buckbee Kevin K | SVP, CONTROLLER | Sell | 1,800 | $172.24 | $310.0K | 0 |
| Aug 5, 2024 | GONZALEZ RICHARD A | EXECUTIVE CHAIRMAN OF BOARD | Sell | 66,500 | $186.52 | $12.40M | 0 |
| Jul 17, 2024 | GONZALEZ RICHARD A | EXECUTIVE CHAIRMAN OF BOARD | Sell | 282,845 | $175.00 | $49.50M | 0 |
| Mar 20, 2024 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 21,082 | $176.30 | $3.72M | 0 |
| Mar 18, 2024 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 58,949 | $178.79 | $10.54M | 0 |
| Mar 1, 2024 | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | Sell | 75,680 | $177.27 | $13.42M | 0 |
| Feb 28, 2024 | Buckbee Kevin K | SVP, CONTROLLER | Sell | 10,483 | $177.84 | $1.86M | 0 |
| Feb 28, 2024 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 16,771 | $178.99 | $3.00M | 0 |
| Feb 28, 2024 | GONZALEZ RICHARD A | CHAIRMAN OF THE BOARD AND CEO | Sell | 248,865 | $178.03 | $44.31M | 0 |
| Feb 28, 2024 | Hudson Thomas J | SVP, CSO, GLOBAL RESEARCH | Sell | 20,634 | $178.99 | $3.69M | 0 |
| Feb 28, 2024 | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | Sell | 106,517 | $177.35 | $18.89M | 0 |
| Feb 28, 2024 | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | Sell | 23,847 | $178.99 | $4.27M | 0 |
| Feb 28, 2024 | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | Sell | 23,966 | $178.99 | $4.29M | 0 |
| Feb 28, 2024 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 17,776 | $178.10 | $3.17M | 0 |
| Feb 28, 2024 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 26,121 | $178.99 | $4.68M | 0 |
| Feb 28, 2024 | Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | Sell | 4,914 | $178.99 | $879.6K | 0 |
| Feb 23, 2024 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Sell | 25,774 | $178.14 | $4.59M | 0 |
| Feb 23, 2024 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 13,753 | $177.51 | $2.44M | 0 |
| Feb 21, 2024 | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | Sell | 52,870 | $173.71 | $9.18M | 0 |
| Feb 2, 2024 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 2,919 | $170.00 | $496.2K | 0 |
| Dec 26, 2023 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 2,912 | $154.72 | $450.5K | 0 |
| Jul 31, 2023 | GONZALEZ RICHARD A | CHAIRMAN OF THE BOARD AND CEO | Sell | 78,500 | $148.71 | $11.67M | 0 |
| May 11, 2023 | Strom Carrie C | SVP & PRES GLOBAL ALLERG AESTH | Sell | 2,876 | $146.42 | $421.1K | 0 |
| Apr 25, 2023 | Sorg Elaine K. | SVP, US COMMERCIAL OPERATIONS | Sell | 6,130 | $165.00 | $1.01M | 0 |
| Apr 17, 2023 | Sorg Elaine K. | SVP, US COMMERCIAL OPERATIONS | Sell | 7,499 | $161.67 | $1.21M | 0 |
| Apr 3, 2023 | Siatis Perry C | EVP, GC AND SECRETARY | Sell | 3,520 | $160.00 | $563.2K | 0 |
| Apr 3, 2023 | Sorg Elaine K. | SVP, US COMMERCIAL OPERATIONS | Sell | 15,002 | $160.03 | $2.40M | 0 |
| Mar 13, 2023 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 53,125 | $152.28 | $8.09M | 0 |
| Mar 5, 2023 | Strom Carrie C | SVP & PRES GLOBAL ALLERG AESTH | Sell | 449 | $156.06 | $70.1K | 0 |
| Feb 28, 2023 | Durkin Brian L | VP, CONTROLLER | Sell | 11,182 | $154.28 | $1.73M | 0 |
| Feb 28, 2023 | GONZALEZ RICHARD A | CHAIRMAN OF THE BOARD AND CEO | Sell | 113,810 | $154.28 | $17.56M | 0 |
| Feb 28, 2023 | Hudson Thomas J | SVP, R&D AND CSO | Sell | 27,922 | $154.28 | $4.31M | 0 |
ABBV Insiders
Similar Stocks to ABBV
LLY
Eli Lilly and Company
$864.41-0.44%
$869.14B
JNJ
Johnson & Johnson
$227.08+0.74%
$555.94B
MRK
Merck & Co., Inc.
$110.50+0.25%
$289.58B
AMGN
Amgen Inc.
$340.40+0.04%
$188.76B
GILD
Gilead Sciences, Inc.
$128.66+0.73%
$168.65B
PFE
Pfizer Inc.
$26.61-0.65%
$156.54B
BMY
Bristol-Myers Squibb Company
$57.98+0.37%
$120.73B
BIIB
Biogen Inc.
$183.00+1.28%
$26.91B